Cambridge, MA, United States of America

Silvana Konermann

This inventor holds 2 USPTO granted patents. Top assignees: Harvard College, Massachusetts Institute of Technology, Rutgers, The State University of New Jersey. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvana Konermann. Retrieved from https://idiyas.com/inventor/silvana-konermann-kd1x01vu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Silvana Konermann: Innovator in CRISPR Technology

Introduction

Silvana Konermann is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genetic engineering, particularly through her work on CRISPR technology. Her innovative approaches have paved the way for advancements in targeting nucleic acids.

Latest Patents

Silvana holds 1 patent related to CRISPR enzymes and systems. This invention provides systems, methods, and compositions for targeting nucleic acids. Specifically, it includes non-naturally occurring or engineered DNA or RNA-targeting systems that comprise a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component, such as a guide RNA.

Career Highlights

Throughout her career, Silvana has worked with esteemed organizations, including the Broad Institute, Inc. and the Massachusetts Institute of Technology. Her work has been instrumental in advancing the understanding and application of CRISPR technology in various fields.

Collaborations

Silvana has collaborated with notable scientists, including Eugene Koonin and Feng Zhang, further enhancing the impact of her research in the scientific community.

Conclusion

Silvana Konermann's contributions to CRISPR technology exemplify her innovative spirit and dedication to advancing genetic research. Her work continues to influence the future of genetic engineering and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…